Stock Taper 
First Solar, Inc., founded in 1999 and headquartered in Tempe, Arizona, designs, manufactures, and sells cadmium telluride PV solar modules globally, serving developers, utilities, and industrial clients.
The Series 7 TR1 is a U.S.-made, high-efficiency cadmium telluride thin-film PV module for utility-scale solar projects, emphasizing advanced technology, low degradation, and First Solar's commitment to domestic manufacturing.
First Solar, Inc. (NASDAQ: FSLR - Get Free Report) saw unusually large options trading activity on Thursday. Stock investors bought 31,358 put options on the stock. This represents an increase of 21% compared to the typical daily volume of 25,870 put options. Wall Street Analysts Forecast Growth Several research firms recently issued reports on FSLR. Jefferies
First Solar stock rose about 2% on Friday, a day after it filed the lawsuit.
First Solar (FSLR) reached $172.11 at the closing of the latest trading day, reflecting a -1.74% change compared to its last close.
PHOENIX--(BUSINESS WIRE)-- #AmericanSolar--First Solar, Inc. (Nasdaq: FSLR) ("First Solar") today announced it has filed a lawsuit against JA Solar Technology Co., Ltd., JA Solar International, Ltd., JA Solar Vietnam Co., Ltd. and JA Solar Industrial Corp. (collectively, "JA Solar"), together with American Panel Solutions LLC ("AMPS"), alleging infringement of First Solar's US Patent No. 9,130,074 (the "'074 Patent"). The '074 Patent covers methods of manufacturing Tunnel Oxide Passivated Contact ("TOPCon") cry.
First Solar (FSLR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Recently, Zacks.com users have been paying close attention to First Solar (FSLR). This makes it worthwhile to examine what the stock has in store.
Shares of First Solar, Inc. (NASDAQ: FSLR - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the thirty-seven research firms that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation, twenty-three have assigned a buy recommendation
Overall rating: B
| PEER | PRICE | |
|---|---|---|
 TRGP | $285.75 | COMPARE |
 CVE | $31.61 | COMPARE |
 WDS | $21.79 | COMPARE |
 EQT | $52.13 | COMPARE |
 CQP | $63.56 | COMPARE |
 HAL | $32.62 | COMPARE |
 PBA | $46.85 | COMPARE |
 EXE | $87.94 | COMPARE |
